Moore H J, Woods E L
J Thorac Cardiovasc Surg. 1985 Feb;89(2):308-10.
Serum antibodies associated with myasthenia gravis were evaluated before and after therapy in an asymptomatic patient having a malignant thymoma. The case illustrates that myasthenia-associated antibodies may also be useful as a tumor marker of thymoma in the work-up of mediastinal masses, in evaluating therapy of thymoma, and possibly in detecting recurrence of thymoma and potential for developing myasthenia gravis.
在一名患有恶性胸腺瘤的无症状患者中,对重症肌无力相关的血清抗体在治疗前后进行了评估。该病例表明,重症肌无力相关抗体在纵隔肿块的检查、胸腺瘤治疗评估、可能在检测胸腺瘤复发以及发生重症肌无力的可能性方面,也可用作胸腺瘤的肿瘤标志物。